Inventor · disambiguated record
Nuruddeen D. Lewis
Also filed as: LEWIS NURUDDEEN · LEWIS NURUDDEEN D
3 granted patents·8 pending applications·11 citations·filing 2016–2025
65Inventor score
Top patents by PatentIndex Score
11 records- 0193US10723782B2Exosomes for immuno-oncology and anti-inflammatory therapyCODIAK BIOSCIENCES INC·Filed 2018·Granted Jul 28, 2020·9 cites·19 claims
- 0291US12331100B2Exosomes for immuno-oncology and anti-inflammatory therapyLONZA SALES AG·Filed 2022·Granted Jun 17, 2025·1 cites·20 claims
- 0383US12030924B2Exosomes for immuno-oncology and anti-inflammatory therapyLONZA SALES AG·Filed 2020·Granted Jul 9, 2024·1 cites·18 claims
- 0477US2025296980A1Exosomes for immuno-oncology and anti-inflammatory therapyLONZA SALES AG·Filed 2025·Application pending·0 cites
- 0549US2022395465A1Sting agonist comprising exosomes combined with il-12 displaying exosomes for treating a tumourCODIAK BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 0648US2025249072A1Methods of treating cancerLONZA SALES AG·Filed 2021·Application pending·0 cites
- 0747US2022251200A1Extracellular vesicles targeting t cells and uses thereofCODIAK BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 0839US2021322327A1Extracellular vesicles comprising sting-agonistCODIAK BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 0937US2022218811A1Methods of treating tuberculosisCODIAK BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1036US2019310250A1Methods for the use of galectin 3 binding protein detected in the urine for monitoring the severity and progression of lupus nephritisMERCK PATENT GMBH·Filed 2017·Application pending·0 cites
- 1128US2018251559A1Methods for the Modulation of LGALS3BP to Treat Systemic Lupus ErythematosusDEMARTINO JULIE·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nuruddeen D. Lewis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →